A Ro alternative for weight loss used to be an easy case to make, because Ro built much of that business on compounded semaglutide before the FDA warned against it. That story changed in 2026. Ro discontinued its compounded program and pivoted to branded Wegovy and Zepbound at cash-pay prices, so the medication supply question that dominated 2024 and 2025 is no longer the deciding factor. What remains is the structural question: who reads your labs every 90 days and who profits when your dose goes up?
We write this as a competitor and we will keep the facts straight. Ro is a legitimate platform selling real medication. We think the structural differences between what they do and what we do matter more than any monthly price and we will lay them out for you to check.
- Ro discontinued its compounded GLP-1 program and now sells branded Wegovy and Zepbound at cash-pay prices.
- The structural comparison is now about clinical depth, lab monitoring and dose-escalation pricing rather than compounded risk.
- GoodLife Health charges a flat $299 per month for the doctor and the quarterly Biomarker Audit, with medication billed separately by the pharmacy at cost and zero markup.
- Two separate charges mean our income never depends on which drug you take or what dose you end up on.
What Ro offers now
Ro's Body program moved to branded GLP-1s in 2026, with Wegovy and Zepbound available at cash-pay prices through the platform. Reported pricing for branded Wegovy through Ro runs in the same range as other major telehealth platforms, commonly reported around $499 to $699 per month depending on the plan and dose. Ro also continues to offer non-GLP-1 weight-loss medications and other products in its catalog.
We do not claim Ro is careless. We claim the model is different from ours in ways worth checking before you commit a year to either.
The structural comparison
| Question | Ro (typical telehealth model) | GoodLife Health |
|---|---|---|
| Who reads your labs? | Screening labs for eligibility, then prescription | Full quarterly Biomarker Audit (ApoB, Lp(a), hs-CRP, HbA1c, lipids, insulin, hormones, thyroid) read by your physician every 90 days |
| What does the fee buy? | Platform access and prescription fulfillment | The doctor, the protocols and the ongoing clinical relationship |
| How is medication priced? | Bundled subscription price | Billed by the pharmacy at cost, zero markup, no molecule upcharge, no dose-escalation fee |
| What happens at dose escalation? | The subscription price may change | Nothing changes. The fee is flat. |
A real objection, named plainly: '$299 plus medication sounds more expensive than a $499 bundle all in.' Here is the math without spin. On a $499 bundle you are paying roughly $5,988 a year with no Biomarker Audit, no quarterly labs and a clinical relationship that is mostly asynchronous messaging. On our model you pay $3,588 a year for the clinical membership ($598 for the first two months, then ten months at $299), plus the actual pharmacy cost of the medication, which you see directly with no markup added by us. Whether the total is lower depends on which drug and dose you need. What is never in question is that we have no financial stake in that answer.
What a real clinical relationship adds
Ro assigns you a licensed provider who reviews your intake and prescribes. That is a legitimate service. What it is not is a physician who has read your ApoB, your Lp(a), your hs-CRP, your thyroid panel and your hormone panel and will read them again in 90 days to see what changed.
The patients who come to us from other platforms usually arrive for one of two reasons: a dose that kept climbing with a bill that climbed with it or a plateau nobody investigated because nobody was watching the labs. Both are failures of clinical depth, not of medication.
Who should actually consider Ro
We will say this plainly because it is fair. If you know exactly which drug and dose you need, you have current labs from another clinician and you want a straightforward cash-pay subscription with a predictable monthly number, Ro does that job well. We are not the right choice for everyone.
We are the better fit when any of the following describes you:
- You want a physician reading your full biomarker panel every 90 days, not screening your eligibility once.
- You have been on a GLP-1 elsewhere and hit a plateau nobody explained.
- You are done with dose-escalation repricing and want a flat fee that never changes with the prescription.
- You want branded FDA-approved medication only, never compounded, stated as a hard rule rather than a policy page.
Frequently asked questions
Does Ro still sell compounded semaglutide?
No. Ro discontinued its compounded GLP-1 program and pivoted to branded Wegovy and Zepbound in 2026. This is a genuine improvement over the compounded era and we say so plainly rather than rehashing an argument the market already settled.
Is GoodLife Health cheaper than Ro?
For the clinical membership, yes: $299 per month (two-month $598 start, then month to month) versus commonly reported branded GLP-1 bundles around $499 to $699 per month. For the all-in monthly total, it depends on which drug and dose you need, because we pass pharmacy cost through at zero markup instead of bundling. The membership never changes with the dose and the medication is billed to you at exactly what the pharmacy charges.
Do I need to switch doctors to switch platforms?
No. Records transfer, prior labs are retrievable and the transition is administrative rather than clinical. We handle the intake, repeat the Biomarker Audit at the next quarterly cycle and take the protocol forward from there.
Will you keep me on my current dose?
Only if the labs and your symptoms support it. We titrate to the least medicine that gets you the most result and we have no financial reason to escalate. If your current dose is doing its job, we keep it. If a lower dose would achieve the same biomarker outcome, we lower it and tell you why.
What if I want medication without a membership?
That is not our model. Every prescription flows from a clinical relationship with quarterly labs, because prescribing a GLP-1 without monitoring is the exact failure mode our practice exists to fix. Several platforms sell medication without clinical oversight and we would rather lose the sale than practice that way.
Is GoodLife Health LegitScript certified?
Yes. Our clinical protocols are LegitScript certified and the physicians delivering care are licensed in all 50 states. Care is delivered by licensed physicians of Beluga Health, P.A., an independent professional corporation, working under GoodLife Health's clinical protocols.
Who should pick Ro instead?
If you know your drug and dose, have recent labs and want a simple cash-pay subscription with a predictable bundle, Ro does that job well. We are the better fit when you want a physician reading the full biomarker panel quarterly or when you are done with dose-escalation pricing and want a flat fee that never changes.
Related guides
- Hims alternative: what to check before you switch
- Cardiometabolic Optimization: the definitive guide
- How GLP-1s work and what happens when they stop
- Our flat-fee model and why it never changes with your dose
External reference: reporting on Ro's Body program and its branded GLP-1 pricing is available from Ro's own site.
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/